Moreover, interruption of Klf5 acetylation promoted tumor growth, accelerated cell proliferation, enhanced the formation of tumor organoids, and altered Smad4-knockout–associated genes in Pten-deficient prostate cancer (Figure 2 and Supplemental Figure 2D). The gene discussed is KLF5; the disease is prostate carcinoma.